Abstract
Most primary CNS lymphomas (PCNSL) are B-cell neoplasms; T-cell lymphomas are quite rare. The authors report two young patients with T-cell PCNSL who had a complete response to chemo- and radiotherapy but developed recurrent disease and died 11 and 13 months from diagnosis. The prognosis of T-cell PCNSL may be worse than that of comparable B-cell tumors.
MeSH terms
-
Adult
-
Antimetabolites, Antineoplastic / therapeutic use
-
Central Nervous System Neoplasms / diagnosis*
-
Central Nervous System Neoplasms / drug therapy
-
Central Nervous System Neoplasms / radiotherapy
-
Cytarabine / therapeutic use
-
Fatal Outcome
-
Humans
-
Lymphoma, T-Cell / diagnosis*
-
Lymphoma, T-Cell / drug therapy
-
Lymphoma, T-Cell / radiotherapy
-
Male
-
Methotrexate / therapeutic use
-
Neoplasm Recurrence, Local / pathology
-
Prognosis
Substances
-
Antimetabolites, Antineoplastic
-
Cytarabine
-
Methotrexate